Top Companies With Best Stability & Growth (10,000+)

Strong Market Position & Advantage: Leader placements in major analyst evaluations (e.g., Gartner’s 2025 Observability MQ—its 13th time—and IDC leadership) indicate durable competitive standing. Reported regional share leadership in Japan further reinforces presence in key markets.

Innovation-Driven Growth: Ongoing platform releases through 2025–2026 (for example, Intelligent Workloads, new AI/Knowledge capabilities, agentic/AIOps features, and Core Observability packaging) signal sustained product investment. A startup program and expanding AI-focused capabilities suggest broadening use cases and upsell potential.

Strategic Partnerships: Strong double-digit year-over-year growth of committed bookings via Microsoft Azure Marketplace and milestone transaction volumes through AWS Marketplace highlight effective channel leverage. These alliances expand reach and can accelerate enterprise adoption.

Innovation-Driven Growth: AI-centric releases, including the “Command Center” beta announced in 2025 and ongoing promotion of Order.co AI through 2026, indicate sustained product investment and expansion. Industry watch lists and awards in 2025–2026 align with momentum tied to these new capabilities.

Investor Backing & Capital Strength: A $30M Series B at rebrand in January 2022 and additional 2026 funding activity noted by private‑market trackers suggest continuing investor support. References to fresh 2026 capital and stable private valuations point to available resources for growth.

Market Expansion: Company materials cite adoption across hundreds of customers and 6,400+ retail locations, along with claims of nearly half a billion to $1B+ in spend processed. Repeated Inc. 5000 recognition and cross‑vertical case studies signal a widening commercial footprint.

Strong Hiring & Retention: Hiring across multiple engineering levels on YC’s Work at a Startup and Idler’s Ashby pages, alongside a listed team size in the low teens, points to active headcount expansion. Several postings state the team is “scaling fast,” consistent with rising demand signals.

Strategic Partnerships: A multimillion-dollar contract with a leading foundation lab—described as the lab’s largest to date—signals substantive enterprise engagement at an early stage. This deal is repeatedly referenced across company and job listings as a central growth driver.

Investor Backing & Capital Strength: Active participation in Y Combinator’s Summer 2025 batch and a disclosed $500K seed round provide institutional backing and initial capital for scaling. External profiles align with a small but expanding team typical of post-accelerator growth.

Strong Revenue Growth: Revenue is accelerating, with FY2025 up 19% and Q1 2026 up 22%, and guidance of $92–$94M implies about 20–22% further growth in 2026. Record analysis volumes and rising net dollar retention support the trajectory.

Strategic Partnerships: High-profile collaborations with Memorial Sloan Kettering (MSK‑ACCESS and MSK‑IMPACT), AstraZeneca, MD Anderson, and large U.S. health systems expand access and credibility for new applications. These relationships are highlighted as drivers of continued double-digit growth through 2026.

Market Expansion: The company is adding customers and scaling usage globally—reaching 537 core genomics customers and a record 108,000 analyses in Q1 2026—with particularly strong momentum in the U.S. and APAC. Reaffirmed U.S. expansion and new application launches are expected to sustain this momentum.

Market Expansion: Geographic rollouts across the U.S. and Canada through 2025–2026, a nationwide U.S. launch, and operations across eight countries point to expanding footprint and service availability. Company posts highlighting new service areas and a fact sheet noting presence in thousands of cities reinforce continued market entry rather than retrenchment.

Strategic Partnerships: Deeper integration into IKEA’s checkout and selling tools in all eight shared markets and the launch of retailer Partner Pages and an API indicate a widening B2B channel that can drive attach and conversion. Owner disclosures and site updates highlight tighter funnel alignment and efforts to win non‑IKEA retail partners.

Product Line Growth: Folding the 2024 Dolly acquisition into the core brand as Taskrabbit Delivery broadens offerings into big‑and‑bulky moving and logistics for consumers and large retailers. Category updates around moving ahead of peak season further signal expansion beyond core tasking.

Strong Revenue Growth: Revenue is reported at $46.1 billion for 2025, up 6.9% year over year, placing the company at No. 100 on the 2026 Fortune 500. These figures indicate expanding scale on a consolidated basis.

Investor Backing & Capital Strength: Total adjusted capital rose to $34.4 billion at year‑end 2025 with all major ratings affirmed, and AM Best assigned “aa-” to a new $1.0 billion surplus‑note issuance. A record estimated $2.9 billion policyowner dividend for 2026 reinforces retained strength for a mutual insurer.

Diversified Revenue Streams: The business spans whole life, annuities, institutional solutions, and asset management via Barings, with additional contributions from Rothesay. Disclosures describe broad‑based sales and earnings across these engines, helping smooth cyclicality.

Investor Backing & Capital Strength: Successive financings of $21M (Aug 2024) and $50M (Aug 2025) are presented as growth capital and corroborated by third‑party outlets. Signals indicate this capital is being deployed toward product expansion and go‑to‑market activity through 2026.

Innovation-Driven Growth: Sustained 2025–2026 product velocity—including AI capabilities (Field Intelligence, Operator AI, Chat AI), payments enhancements, and broader platform updates—points to active investment to scale. Case studies and a Spring 2026 product keynote further indicate new capabilities are shipping at pace.

Strategic Partnerships: New integrations and alliances (e.g., Thumbtack, The Granite Group, CompanyCam, CHIIRP, XAPP AI) expand ecosystem reach and potential demand generation. These arrangements are positioned to strengthen distribution and customer acquisition.

Market Expansion: Geographic reach has broadened to about 25 U.S. states for Care+ in‑home preventive visits, with coverage spanning Medicare, Medicaid, and Marketplace lines of business. Materials from 2023–2026 indicate a step‑up from 5 states to roughly half the nation by February 2026.

Strategic Partnerships: Collaborations with payers and providers are expanding, exemplified by Blue Cross Blue Shield of Michigan/Blue Care Network offering in‑home diabetic retinal screenings starting April 1, 2026 and UCI Health signaling plans to grow joint programs. Additional references highlight added payer/provider relationships through 2025–2026.

Investor Backing & Capital Strength: A $55 million Series B closed on May 15, 2025 led by General Catalyst with participation from a16z Bio + Health and others, providing fuel to scale at‑home services. Third‑party trackers and coverage cite total funding in the roughly $92.6 million to ~$125 million range.

Strong Revenue Growth: ARR is estimated to have risen from roughly $230M in 2022 to about $310M by end-2023, indicating sustained top-line momentum. Public signals such as millions of businesses served and a large integrations catalog align with this trajectory.

Innovation-Driven Growth: Product scope has expanded beyond “zaps” into first-party tools like Tables and Canvas while adding AI features including Copilot, Agents, and orchestration. This steady launch cadence broadens use cases and supports ongoing platform monetization.

Market Expansion: Packaging and capability updates—such as the new Enterprise plan (April 2024) and SSO on Team—reflect a deliberate move up-market. These changes typically enable larger deployments and higher-value customer relationships.

Strong Revenue Growth: Revenue is described as nearing roughly $1 billion in 2025 while live-sales GMV more than doubled from about $3 billion in 2024 to $6–8 billion by 2025–mid‑2026. Reporting also highlights milestone order volume and strong seasonal spikes that align with this acceleration.

Market Expansion: The company is expanding beyond collectibles into fashion, beauty, electronics, and other categories, and has grown across the U.S., U.K., Europe, and Australia. An acquisition to enhance real‑time recommendations and the launch of dozens of new categories underscore a widening footprint.

Investor Backing & Capital Strength: Successive late‑2025 rounds lifted valuation from roughly $5 billion to about $11.5 billion, with substantial capital raised to fund further scale. This up-round trajectory is presented as clear investor confidence in the growth plan.

Investor Backing & Capital Strength: Capital comes from a $6M seed round raised by the parent company Tildei in late 2024, providing runway for product and go‑to‑market buildout. This funding base supports continued growth initiatives for Runhappy under the Tildei umbrella.

Future-Ready Strategy: Enterprise signals include a dedicated Trust Center outlining security controls and subprocessors, indicating maturing processes typical of a scaling B2B platform. These foundations suggest preparedness for larger customers’ compliance expectations.

Strong Brand Reputation: Named customer testimonials and a case study from American Dream, Studs, and Five Star cite measurable impact (e.g., 3.42x ROAS and 1‑in‑5 conversations converting), signaling credible outcomes. Public logos and detailed stories enhance referenceability with prospective buyers.

Strong Hiring & Retention: Hiring pipelines are active on the company’s careers site and external boards, with roles like Director of Digital Design and Senior Software Engineer indicating added capacity. Employer-brand recognition such as Built In’s ongoing “Best Places to Work” listings aligns with continued talent attraction.

Innovation-Driven Growth: Portfolio outcomes include building Nativo, which was acquired by Life360 for about $120 million in early 2026, reinforcing a studio model that scales ventures through to meaningful exits. Additional outcomes like Cie Games, Titan, and ASAP Tire further suggest a repeatable build-to-exit approach.

Strategic Partnerships: Collaborations with major brands such as Petco, Pilot Flying J, Leslie’s Pool, and Nitto are highlighted as part of commercialization and venture scaling. This enterprise network supports new-co creation and market access within the studio’s model.

Product Line Growth: New product waves include a next‑generation cup portfolio in July 2026 and an entry into infant formula, alongside breastfeeding accessories like the FLOW Nipple Shield+, signaling active pipeline investment across core and adjacent categories.

Strong Market Position & Advantage: Category leadership is evidenced by being the No. 1 brand in cups for the 52 weeks ending May 17, 2026, with frequent best‑of awards reinforcing sustained strength in key subcategories.

Market Expansion: Distribution spans 50+ countries with recent launches in Japan via DADWAY and broad placement at major U.S. retailers, indicating continued geographic and channel expansion.

Investor Backing & Capital Strength: Capital levels are stronger, with the net worth ratio rising from 8.94% at year-end 2023 to 9.69% at year-end 2024 alongside $6.4M in 2024 net income. This indicates an improved capital cushion supporting ongoing initiatives.

Market Expansion: A new digital brand, CineFi, launched in January 2026 to serve entertainment professionals in the Atlanta metro, extending reach beyond Southern California. This marks a targeted geographic growth move aligned with its niche.

Product Line Growth: Non-interest revenue expanded as the insurance unit reported 3,550 policies and $957k in 2024 revenue, up 14% year over year. Product and program enhancements were also highlighted as part of the growth posture.

Strong Revenue Growth: Revenue is described as reaching a record in Q4 FY26, with company updates also pointing to a continued ARR growth trajectory and strong Q1 FY27 performance. Platform spend flowing through the network in multiple quarters (e.g., hundreds of billions of dollars) underscores rising activity aligned with this momentum.

Market Expansion: Customer additions and expansions are frequent, including 100+ new logos in Q4 FY26, nearly 300 new customers in FY26, and 320+ new or expanded relationships in Q4 FY25 with over 1,450 for FY25. Subsequent quarters cite dozens of new logos and hundreds of renewals/expansions, indicating a widening footprint.

Innovation-Driven Growth: New AI offerings (Coupa Compose/Catalyst and Navi AI agents) and the Rossum acquisition broaden automation and document processing, supporting upsell and adoption. Company updates link strong quarterly performance to agentic AI and workflow automation.

Investor Backing & Capital Strength: Capital raises and valuation step‑ups are prominent, including a $100M Series D in July 2024 at a reported $2.3B valuation to fund expansion into Medicare Advantage and Medicaid. Independent coverage and company materials corroborate the round and use of proceeds.

Market Expansion: Nationwide availability (all 50 states + D.C.) and moves into Medicare Advantage (targeted 51 markets by end‑2024) with Medicaid launches planned for 2025 broaden the addressable market. Company updates indicate these government lines are now active in select states.

Strategic Partnerships: Payer connectivity has accelerated from roughly 40 to 70+ plans with preferred‑network status at major carriers, and revenue scales with completed sessions rather than sign‑ups. These relationships underpin growing patient access and utilization.

Investor Backing & Capital Strength: Ownership by KIRKBI, which acquired BrainPOP in 2022, provides long-term capital and a mandate to invest and expand. Communications around the deal describe continued independence with resources to drive the next phase of growth.

Product Line Growth: The company has expanded from core K–8 videos into BrainPOP Science for grades 6–8 and continues to roll out updates. Earning ESSA Level 3 (“promising evidence”) in 2026 supports district purchasing and broadens adoption.

Strong Market Position & Advantage: At acquisition, the company reported presence in over two‑thirds of U.S. districts and an estimated 25 million students reached annually. This installed base and distribution create a platform for ongoing expansion.

Profitability: Net income climbed from $81.7M in 2024 to $111.4M in 2025 alongside growth in the balance sheet. This points to stronger earnings capacity supporting expansion.

Resilient & Sustainable Growth: Primary membership, assets, and loans all increased year over year (members 901,055 to 923,396; assets $19.54B to $20.27B; loans $15.31B to $16.04B). Company messaging and independent profiles also highlight 2025 as a year of record growth at roughly $20B in assets.

Cost & Operational Efficiency: A branchless, digital‑first model kept operating expense ratios low (about 1.24% in 2024 and 1.27% in 2025). This efficiency posture supports scalable growth and competitive pricing.

Strong Revenue Growth: Recognition on the Inc. 5000 in 2023 and 2024 points to multi‑year revenue expansion, and Learneo previously disclosed $200M+ combined revenue and 3M+ annual subscriptions at its 2022 platform launch. These signals indicate momentum even if the most current operating figures are not publicly updated.

Product Line Growth: Acquisitions in 2023 added LanguageTool and Barnes & Noble Education’s Digital Student Solutions (bartleby and Student Brands), bringing the portfolio to eight businesses including Course Hero, QuillBot, Scribbr, Symbolab, CliffsNotes, and LitCharts. This broadened mix extends capabilities across writing assistance, study support, and math problem‑solving.

Investor Backing & Capital Strength: A $395M Series C round at a $3.6B valuation provided substantial capital to fund M&A and product development. This financing base supports ongoing strategic initiatives despite market volatility.

Investor Backing & Capital Strength: A $30M Series A announced on March 24, 2026—led by Fulcrum Equity Partners with participation from Amex Ventures and TTV Capital—provides material scale-up capital. Third-party trackers and industry outlets also record this round.

Strategic Partnerships: A strategic relationship with Equifax (April 2024) and named enterprise deployments/integrations such as REPAY, PatientFi, Priority, and Aurora Payments indicate expanding ecosystem reach. These relationships suggest traction across payments, fintech, and healthcare segments.

Innovation-Driven Growth: Product and roadmap updates highlight expanded data coverage (1,100–1,200+ data points), explainable scoring, Lightning Verify, and initiatives like a Worth Wallet and KYA frameworks. These developments indicate ongoing investment to broaden automation and decisioning capabilities.